Icesp

What Icesp does

ICESP (Instituto do Câncer do Estado de São Paulo) is a public oncology hospital inaugurated on 6 May 2008 and headquartered at Av. Dr. Arnaldo, 251 in the Cerqueira César district of São Paulo, Brazil. It operates exclusively within the Brazilian Unified Health System (SUS), the country's public health network, and serves as one of the largest oncology centers in Latin America — reporting more than 150,000 patients treated cumulatively, ~40,000 active patients, 3.5 million medical consultations, 2.5 million multiprofessional consultations, 800,000+ chemotherapy sessions, 820,000+ radiotherapy sessions, 419,000+ emergency/urgency visits and 126,000+ surgeries since inception. The institute is operated by the private nonprofit Fundação Faculdade de Medicina (FFM, CNPJ 56.577.059/0006-06) under contract with the São Paulo State Government, and is structurally embedded within the Hospital das Clínicas da Faculdade de Medicina da USP (HC-FMUSP) system, sharing faculty, governance and research infrastructure with FMUSP.

Its care footprint spans four sites — the 520-bed Matriz on Av. Dr. Arnaldo, the Unidade Ambulatorial de Osasco, the Farmácia Ambulatorial on Rua da Consolação, and the Itaci pediatric oncology unit — delivering SUS-funded multidisciplinary oncology care (chemotherapy, radiotherapy, conventional and robotic surgery, Iodine-131 therapy, supportive/palliative care). Patient-facing technology includes the Portal do Paciente HC mobile app for appointments, exam results and teleconsultations, and the Icesp Collaborator app for staff.

The institute's research infrastructure is its principal technological differentiator: the Center for Translational Research in Oncology (CTO-LIM24) coordinates molecular oncology, glycobiology, viral-vector gene therapy, cancer stem cells and breast-cancer genomics labs; the Research Center (NP-ICESP, inaugurated 2012) provides 598 m² of ICH-GCP-compliant clinical-trial infrastructure including a 7-chair infusion room and experimental-drug pharmacy; the Center of Nuclear Medicine (CMN-LIM43) houses a GMP-certified Cyclotron producing novel molecular imaging probes alongside an integrated PET/SPECT/CT preclinical imaging device; the USP Academic Biobank of Research on Cancer (CEP/CONEP-approved 1 Oct 2014) stores high-quality biospecimens for biomarker discovery; and the PREMiUM multi-user equipment network provides shared DNA sequencing, genotyping, flow cytometry and a forthcoming Hypoxia Workstation H35. The Center for Realistic Health Simulation (CSRS) supports residency training, and the Medical Residency Program in Clinical Oncology was ranked top 5 worldwide in the ASCO global exam (74% average, Feb 2026).

The business model is a managed-services, SUS-funded operating structure: patient care is provided free at the point of use, with the hospital funded by São Paulo State Government budget allocations through FFM/FMUSP rather than direct fees. Supplementary revenue streams include donations via doaricesp.org.br (and structured Santander bank transfer instructions), research grants from FAPESP and NIH/NIGMS, and cost-recovery from industry-sponsored clinical trials (Phases I–IV) run via NP-ICESP with pharmaceutical, biotechnology and medical-device partners.

Name

Icesp

Legal name

Instituto do Câncer do Estado de São Paulo (ICESP)

Website

https://icesp.org.br

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

ICESP is a public oncology hospital in São Paulo, Brazil, serving SUS patients with multidisciplinary cancer care, translational research, and graduate medical training, operated by FFM within the FMUSP/HC system as one of the largest oncology centers in Latin America.

Ownership category

akta.pro rank

Product category

Public Oncology Hospital Services

NAICS

General Medical and Surgical Hospitals (622110), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Investigator & Site Training / GCP Support (HLAGACAF)

Keywords

• Oncology treatment
• Cancer care
• Clinical research
• Translational oncology
• Medical residency

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Public Health System (SUS) Funding: ICESP is operated within the SUS (Sistema Único de Saúde) public health system, managed in partnership with the Fundação Faculdade de Medicina (FFM) and Faculdade de Medicina da USP (FMUSP). Care is delivered exclusively through the public health network and is not directly billed to patients. The hospital is one of the largest oncology centers in Latin America, with 18 years of operation.
2. Donations and Fundraising: Donations are solicited through a dedicated portal (doaricesp.org.br / doaricesp.org.br), and proceeds support institutional activities. Donation instructions indicate Banco Santander 033, Agência 0201, Conta Corrente 13-005061-5, beneficiary Fundação Faculdade de Medicina/ICESP, CNPJ 56.577.059/0006-06.
3. Research Grants and Public Notices (Editais): Clinical research projects are funded via public notices (Editais ICESP/FFM) and external grants, with the NP-ICESP acting as central office for negotiating agreements, organizing budgets and facilitating execution of studies. Research funding sources referenced include FAPESP and the NIH/NIGMS Consortium for Functional Glycomics.
4. Sponsored Clinical Trials and Industry Partnerships: The Clinical Research program runs partnerships with biotechnology laboratories, the pharmaceutical industry and prosthesis/equipment developers for oncology clinical studies (Phases I–IV, including preclinical and post-marketing studies). Industry-sponsored studies generate cost-recovery and infrastructure support for the Núcleo de Pesquisa.

Go-to-market motion3 records

Distribution channels7 records

Marketing channels9 records

Core offering

Icesp is a public oncology hospital within the SUS (Sistema Único de Saúde) network that delivers comprehensive cancer care — including chemotherapy, radiotherapy, conventional/robotic/outpatient surgery, Iodine-131 therapy, emergency oncology, palliative care and multiprofessional consultations — exclusively to SUS patients in São Paulo state. Beyond clinical care, Icesp runs oncology residency and postgraduate training programs accredited by FMUSP and operates translational and clinical research infrastructure (CTO-LIM24, NP-ICESP, CMN-LIM43, USP Academic Biobank, PREMiUM equipment network) supporting investigator-initiated and industry-sponsored Phase I–IV clinical trials.

Differentiator

Problem solved

Functional benefit

Brands

• Portal do Paciente HC: Mobile application for patients to access appointments, exam results and teleconsultations.
• Aplicativo do Colaborador Icesp
• Prêmio Octavio Frias de Oliveira
• SP Câncer

Products and services

• Comprehensive Public Oncology Care (SUS) Free multidisciplinary cancer care delivered exclusively through the SUS public health system to adult and pediatric oncology patients, covering chemotherapy, radiotherapy, conventional/robotic/outpatient surgery, Iodine-131 therapy, emergency oncology, palliative care and multiprofessional consultations.
• Research Center (NP-ICESP) Clinical Trials Service Central office coordinating all human-subject oncology studies (Phase I–IV, including preclinical and post-marketing studies) under ICH-GCP and CONSORT standards, with 598 m² of dedicated infrastructure including a 7-chair infusion room, sample processing laboratory, stock room, experimental drug pharmacy and monitoring area. Open to industry-sponsored and academic sponsors.
• Medical Residency in Clinical Oncology (FMUSP at Icesp) FMUSP-accredited Medical Residency Program in Clinical Oncology delivered at Icesp, with a track record of top-5 global performance in the ASCO exam. Open to medical residents from across Brazil and abroad.
• Multiprofessional Residency in Adult Oncology Care Multiprofessional residency program in adult oncology care (including translational and innovation specialization tracks) for non-physician health professionals, delivered at Icesp.
• Stricto Sensu Graduate Program in Oncology (FMUSP) CAPES-accredited (score 4) postgraduate program (master's and doctoral) in clinical and experimental oncology, run by FMUSP at Icesp, with interdisciplinary and international exposure for scientific leaders in oncology.
• Portal do Paciente HC mobile application Mobile application (iOS and Android) developed jointly with Hospital das Clínicas – FMUSP that lets patients view appointments, exam results and teleconsultations. Distributed on Google Play and the Apple App Store.
• Aplicativo do Colaborador Icesp Internal Android application for Icesp staff providing corporate discounts and partnerships, quality-of-life programs, HR guidance, online and in-person courses, open internal selection processes and risk-management notifications.

Quantifiable outcome

• +150,000 patients served since inauguration (May 2008–May 2026)
• +7 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• Hospital das Clínicas da Faculdade de Medicina da USP (HC-FMUSP)flagshipStrategic or Co-development PartnerIcesp operates as part of the FMUSP/HC System, sharing clinical, teaching and research infrastructure. The logo of HC-FMUSP appears alongside Icesp on the institutional site, and HC-FMUSP researchers collaborate via the Núcleo de Pesquisa, CTO and CMN. Icesp's Director of the Division of Oncology is also a Full Professor at the FMUSP Discipline of Clinical Oncology.
• Fundação Faculdade de Medicina (FFM)flagshipStrategic or Co-development PartnerFFM is Icesp's co-management and fundraising entity; the Trabalhe Conosco page redirects candidates to vagas.com.br/ffm, donation receipts are issued under FFM/ICESP (CNPJ 56.577.059/0006-06), and Editais ICESP/FFM (editais.icesp.org.br) are administered jointly.
• Faculdade de Medicina da Universidade de São Paulo (FMUSP)flagshipStrategic or Co-development PartnerFaculty of FMUSP Disciplina de Oncologia have their headquarters at Icesp; Icesp offers Medical Residency, Multiprofessional Residency, Master's (Stricto Sensu), Lato Sensu specializations, observerships, internships, fellowships and Continuing Education programs accredited by FMUSP. The FMUSP Intellectual Production Observatory hosts Icesp's scientific production.
• Governo do Estado de São PauloflagshipStrategic or Co-development PartnerPublic-sector sponsor/partner; the São Paulo State Government logo is displayed on the institutional site. Icesp serves exclusively SUS patients in the state of São Paulo and is part of the state public-health structure.
• Grupo FolhacoreGTM or Marketing PartnerGrupo Folha sponsors the annual Prêmio Octavio Frias de Oliveira, hosted by Icesp and aimed at stimulating scientific research in cancer prevention and control across three categories: Oncology Research, Featured Personality, and Technological Innovation in Oncology. The judging commission also includes representatives of Folha de S. Paulo.
• Instituto Nacional de Câncer (INCA)coreStrategic or Co-development PartnerINCA participates as a research partner in Icesp's 2nd Clinical Research in Cancer Webinar (20 May 2026) — Dra. Alexssandra Lima Siqueira dos Santos presented "Pesquisa no SUS – Experiência do INCA". INCA is Brazil's national cancer institute.
• Nanomed (startup co-founded by Prof. Valtencir Zucolotto)minorStrategic or Co-development PartnerProf. Valtencir Zucolotto of the Nanomedicine and Nanotoxicology Laboratory (LNN/IFSC-USP) is Co-Founder and Chief of Scientific Committee of Nanomed, a startup focused on nanoformulations for cosmetics and healthcare. His research on theranostic nanomaterials is part of the USP Cancer Research Academic Network that interfaces with Icesp.

Scale indicators16 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Hospital Israelita Albert Einstein: One of Latin America's leading hospitals (São Paulo), with a dedicated oncology center, translational research institute and residency programs. Direct comparable in scale and academic standing; differs in being private/pay-mixed rather than SUS-exclusive.
• Hospital Sírio-Libanês: Major São Paulo tertiary hospital with a well-known oncology center and research institute, serving both private and SUS patients. Comparable to ICESP in clinical complexity, residency training and clinical research activity.
• MD Anderson Cancer Center: Global benchmark dedicated oncology hospital with massive Phase I trial program, GMP manufacturing, biobank and residency. ICESP faculty and training model are partially calibrated to MD Anderson; useful as the global scale peer for translational research trajectory.
• Memorial Sloan Kettering Cancer Center: US specialty oncology hospital with a leading clinical research program and top-ranked oncology residency. Comparable to ICESP on residency ranking signal and Phase I trial volume, at materially larger scale.
• Gustave Roussy Institute: European reference oncology hospital in France combining care, research and teaching. Comparable to ICESP as an integrated public oncology center with translational research platforms and Phase I trial activity.

Direct peers

• A.C. Camargo Cancer Center: Dedicated oncology hospital in São Paulo with integrated research, teaching (residency) and clinical trial programs. The closest direct peer — same city, same oncology-only mandate, comparable Phase I–IV trial footprint and biobank activity.
• Hospital de Amor (Barretos): Large SUS-funded oncology hospital network headquartered in Barretos with multiple regional units across Brazil. Direct comparable on SUS-exclusive public oncology mandate, residency training and clinical trial activity; differs in being multi-state rather than São Paulo-concentrated.
• Instituto Nacional de Câncer (INCA): Brazil's federal cancer institute (Rio de Janeiro) — national reference for oncology with clinical research, residency and public-health coordination. Direct comparable on public cancer mandate, INCA is a named webinar and research partner of ICESP.
• Hospital das Clínicas da FMUSP: The flagship HC-FMUSP complex that hosts ICESP and shares faculty, governance, infrastructure and the Portal do Paciente HC mobile app. Effectively the parent hospital system; directly comparable on academic public-hospital scale, residency programs and clinical research platform.

Regional players

• Hospital de Clínicas de Porto Alegre (HCPA): Federal university hospital in southern Brazil with a strong oncology and clinical research program (PPG and residency). Comparable to ICESP on the academic public-hospital model; operates in a different geographic region (Rio Grande do Sul).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Icesp_
• YouTubeyoutube.com/user/InstitutodoCancer
• Facebookfacebook.com/InstitutodoCancerSP
• LinkedInlinkedin.com/company/institutodocancersp
• Instagraminstagram.com/institutodocancersp

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Icesp